KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Current Leases (2020 - 2025)

Historic Current Leases for Recursion Pharmaceuticals (RXRX) over the last 6 years, with Q3 2025 value amounting to $11.5 million.

  • Recursion Pharmaceuticals' Current Leases rose 3998.54% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 3998.54%. This contributed to the annual value of $13.8 million for FY2024, which is 12555.59% up from last year.
  • Latest data reveals that Recursion Pharmaceuticals reported Current Leases of $11.5 million as of Q3 2025, which was up 3998.54% from $11.7 million recorded in Q2 2025.
  • Recursion Pharmaceuticals' 5-year Current Leases high stood at $13.8 million for Q4 2024, and its period low was $499000.0 during Q1 2021.
  • In the last 5 years, Recursion Pharmaceuticals' Current Leases had a median value of $5.7 million in 2022 and averaged $6.5 million.
  • Per our database at Business Quant, Recursion Pharmaceuticals' Current Leases soared by 95050.1% in 2022 and then crashed by 335.68% in 2023.
  • Recursion Pharmaceuticals' Current Leases (Quarter) stood at $1.4 million in 2021, then soared by 320.34% to $6.0 million in 2022, then grew by 2.76% to $6.1 million in 2023, then skyrocketed by 125.56% to $13.8 million in 2024, then decreased by 16.46% to $11.5 million in 2025.
  • Its Current Leases was $11.5 million in Q3 2025, compared to $11.7 million in Q2 2025 and $11.9 million in Q1 2025.